Proactive Investors - Run By Investors For Investors

Imugene adds key members to its scientific advisory board to advance company forward

Imugene Ltd (ASX:IMU) CEO Leslie Chong sat down with Proactive Investors at the 11th Annual Biotech Showcase in San Francisco.

Imugene is an Australian biotechnology company with operations in the U.S. and in Europe, developing cancer immunotherapies targeting B-cell peptide vaccines.

View full IMU profile View Profile

Imugene Ltd Timeline

© Proactive Investors 2019

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use